News

Straive Acquires Gramener to Enhance Data, Analytics,and AI Capabilities

Reading Time: 2 mins

Singapore (Nov 1, 2023): Straive, a leader in helping organizations operationalize the data -> insights -> knowledge -> AI value chain announced the acquisition of Gramener, an award-winning, design-led data science company. Straive is owned by BPEA EQT, part of EQT a purpose-driven global investment organization focused on active ownership strategies.

Gramener helps solve complex business problems with compelling data stories using insights and a low-code AI-powered platform for clients across multiple industries, including Pharmaceuticals & Life Sciences, Logistics & Manufacturing, ESG, and Technology & Consulting. Gramener’s AI-led platform leverages Computer Vision, NLP (Natural Language Programming), NLG (Natural Language Generation), and Spatial Analytics

Straive helps clients create differentiated customer experiences, offerings and operations by embedding unique data-driven insights and expert knowledge into digital & AI technologies which are operationalized with experts-in-loop.Our clients can immediately accelerate their data/AI powered transformation journey by leveraging Gramener’s experienced team, cutting-edge AI and analytics capabilities and multi-industry experience” said Ankor Rai, CEO of Straive.

Namit Sureka, President and Chief Analytics & AI Officer, Straive, commented. “Gramener’s capabilities across the data value chain, especially their depth in AI and Data Science, complement Straive’s existing data, knowledge, and operations capabilities. We believe that their team of experts who bring high energy, entrepreneurial spirit, and differentiated offerings through innovation will significantly enhance our positioning and deliver impact for our clients.

On behalf of the entire team at Gramener, we are excited to become part of Straive and believe that combining our strengths will enable the creation of differentiated, end-to-end offerings from Data to AI and, ultimately Gen AI to accelerate our vision of enterprise decision making with insightful stories” said Anand S, Co-Founder and CEO, Gramener.

Naveen Gattu, Co-Founder and COO, Gramener, commented “We are aligned in our commitment to partnering with clients and nurturing data/AI-led growth. Partnering with Straive allows us to offer comprehensive data services, spanning from data extraction and engineering to data science , visualization, and AI. This positions us at a competitive advantage as we continue to create value for our clients.

Avendus Capital Private Limited served as the exclusive financial advisor to Gramener.

About Gramener

Gramener is an award-winning, design-led data science company. Gramener helps solve complex business problems with compelling data stories using insights and a low-code AI-powered platform for clients across multiple industries, including Pharmaceuticals & Life Sciences, Logistics & Manufacturing, ESG, and Technology & Consulting.  The company operates from 6 locations across the USA, India, Switzerland, Canada, and Singapore.

About Straive (Erstwhile SPi Global)

Straive helps clients operationalize the data -> insights -> knowledge -> AI value chain. Straive’s clients extend across Financial & Information Services, Insurance, Healthcare & Life Sciences, Scientific Research, EdTech, and Logistics.  Straive has locations across multiple geographies including United States, UK & Europe, Singapore, India, Philippines, Nicaragua and Vietnam.

For media queries, contact Vijay Nair, Head of Marketing & Growth (vijay.nair@gramener.com 

Sunil Sharma

Sunil is an Asst. Marketing Manager at Gramener. He is exploring his interest in generative AI and loves to write about impactful business stories and trends in data science & analytics, including data storytelling.

Leave a Comment
Share
Published by
Sunil Sharma

Recent Posts

Top Generative AI Use Cases in Healthcare

The emergence of Generative AI (GenAI) is reshaping healthcare use cases and facilitating the rapid… Read More

3 days ago

Generative AI in Pharma Regulation: Insights from FDA, EMA, and Health Canada

The U.S. Food and Drug Administration's (FDA) stance on GenAI is clear: it's a groundbreaking… Read More

1 week ago

AInonymize – AI for Secure Health Data and Innovation

Executive Summary In healthcare, protecting patient information is not just a legal requirement; it's a… Read More

2 weeks ago

How Demand Forecasting Turns Supply Chains into Mind Readers?

Demand forecasting in the supply chain is crucial for optimizing inventory levels and ensuring efficient… Read More

3 weeks ago

LLM Numerology: We Experimented with 3 LLMs to Find Out Their Favorite Numbers

Hi, I am ChatGPT 3.5 Turbo. Do you know what my favorite number is? Do… Read More

1 month ago

Data-Driven Sustainability: Achieve Business Value from ESG Data

After a successful webinar on digital transformation and sustainability, we organized a sequel titled “Data-Driven… Read More

1 month ago

This website uses cookies.